Ignite Creation Date:
2024-05-05 @ 11:49 AM
Last Modification Date:
2024-10-26 @ 9:14 AM
Study NCT ID:
NCT00145262
Status:
UNKNOWN
Last Update Posted:
2005-12-30
First Post:
2005-09-02
Brief Title:
TACT-NAGOYA Therapeutic Angiogenesis Using Cell Transplantation
Sponsor:
Nagoya University
Organization:
Nagoya University
Study Overview
Official Title:
Therapeutic Angiogenesis Using Cell Transplantation TACT Study at Nagoya
Status:
UNKNOWN
Status Verified Date:
2003-08
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Clinical studies have established that implantation of bone marrow mononuclear cells BM-MNCs or peripheral blood mononuclear cells PB-MNCs into ischaemic limbs increases collateral vessel formation We the investigators at Nagoya University further investigated the efficacy and safety of autologous implantation of BM-MNCs or PB-MNCs in patients with severe ischaemic limbs who have no other alternative therapeutic options We also examined a potential limiting factor which reduced the efficacy of therapeutic angiogenesis using cell transplantation TACT
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None